Trypanosoma cruzi is a kinetoplastid flagellate protozoan that causes Chagas disease in Latin America, where 75-90 million are exposed to the infection. Studies have estimated that currently 15-16 million people are infected with this parasite (Coura & Dias 2009) . T. cruzi has a life cycle that includes invertebrate (triatomine bugs) and vertebrate (mammals) hosts. During its cycle, the parasite undergoes drastic morphological alterations in cell shape, which result in at least three major evolutive forms. Each form has adapted for living in specific environments inside the hosts. Although epimastigote forms are exclusive to the insect vector, trypomastigotes (bloodstream forms) and amastigotes (intracellular forms) are associated with vertebrate hosts (de Souza 1984) .
T. cruzi differentiation from the epimastigote to the trypomastigote stage in the insect rectum (metacyclogenesis process) is critical for the generation of infective metacyclic trypomastigotes. Furthermore, intracellular differentiation from trypomastigotes to amastigotes (and then back to trypomastigotes) is essential for evading the host's immune response and maintaining the infection in the mammalian host. Therefore, studies on these processes may help to elucidate their functioning and indicate potential targets for the development of trypanocidal drugs. This is relevant because the currently available drugs (nifurtimox and benznidazole) are not fully effective and present serious, toxic side effects (Coura & de Castro 2002 , Urbina 2009 ).
Essential oils are sources of phytotherapeutic agents that have traditionally been used by native cultures to treat infectious diseases. Their use as antimicrobial and antifungal agents has been firmly established for decades (Burt 2004) . More recently, studies have shown that essential oils may also be used as anti-protozoal drugs. Indeed, essential oils have inhibitory actions against diverse parasitic protozoa, such as Plasmodium falciparum (Valentin et al. 1995) , Trypanosoma brucei, Leishmania major (Mikus et al. 2000) , Leishmania amazonensis (Monzote et al. 2006 , Santin et al. 2009 and T. cruzi (Santoro et al. 2007a, b, c) .
Interestingly, the essential oil of Cymbopogon citratus (DC) Stapf (Gramineae) has anti-fungal and antibacterial activities (Onawunmi et al. 1984 , Onawunmi 1989 , Ibrahim 1992 , Mishra & Dubey 1994 , Viollon & Chaumont 1994 , Wannissorn et al. 1996 , Cimanga et al. 2002 . This essential oil has been shown to be effective against protozoa and significantly reduced the growth of Plasmodium berghei (Tchoumbougnang et al. 2005) , the insect trypanosomatid Crithidia deanei (Pedroso et al. 2006) , L. amazonensis (Santin et al. 2009 ) and all three evolutive forms of T. cruzi (Santoro et al. 2007a) .
Because the T. cruzi differentiation process plays a major role in the life cycle of the parasite, understanding and influencing this process is a primary research interest. Citral, the main constituent of C. citratus (lemongrass) essential oil, showed a high activity against T. cruzi bloodstream trypomastigotes (Santoro et al. 2007a) , with a concentration that induced 50% cell lysis (IC 50 ) of about 15 μg/mL. Therefore, the present study investigated the effect of citral on the epimastigote-to-trypomastigote metacyclogenesis process of T. cruzi in vitro by growing the parasites in triatomine artificial urine (TAU)3AAG, which is a chemically defined medium that induces parasite differentiation (Contreras et al. 1985) . 
MATERIALS AND METHODS
Drugs -Citral, an isomeric mixture of geranial and neral ( Fig. 1) , was purchased from Sigma (Sigma-Aldrich, St. Louis, MO, USA) and initially diluted in dimethyl sulphoxide (DMSO) at a concentration of 100 mg/ mL. This solution was then diluted in TAU or TAU3AAG culture media to obtain a second stock solution at 1 mg/ mL (the DMSO was diluted to 1%). Stock solutions were stored at 4ºC and used within one month. Stock solutions prepared in culture media were diluted at different concentrations for the experiments (20, 40, 60, 80 or 100 µg/ mL). Under this setting, the final DMSO concentration in the assays never exceeded 0.1%. Thus, the potentially toxic effects of DMSO did not affect protozoa.
Parasite -T. cruzi strain Dm28c (Contreras et al. 1988 ) was used in the experiments. Culture epimastigote forms were kept at 28ºC in liver infusion tryptose (LIT) medium (Camargo 1964) supplemented with 10% foetal bovine serum. The epimastigotes were passaged weekly.
Epimastigote-to-trypomastigote differentiationFor in vitro metacyclogenesis, 5-day-old culture epimastigotes were harvested by centrifugation at 7000 g for 10 min at 10ºC. The parasites were then incubated for 2 h at 28ºC at a density of 5 x 10 8 cells/mL in TAU medium (190 mM NaCl, 17 mM KCl, 2 mM MgCl 2 , 2 mM CaCl 2 , 8 mM phosphate buffer, pH 6.0). Thereafter, the parasites were incubated at a 1:100 dilution (final epimastigotes concentration: 5 x 10 6 cells/mL) for 96 h at 28ºC in TAU3AAG medium (TAU supplemented with 10 mM L-proline, 50 mM L-sodium glutamate, 2 mM L-sodium aspartate and 10 mM D-glucose) in 25 mL culture flasks with a layer of culture medium that was not more than 1 cm in depth (Contreras et al. 1985) . All experiments were performed with a final parasite concentration of 5 x 10 6 epimastigotes/mL, which was a condition that allowed the best differentiation rates. Thus, after 72 h of cultivation, about 80% of the cells in the supernatant were in the trypomastigote form.
Culture supernatants were collected after 24, 48 and 72 h of incubation in TAU3AAG medium and the number of living epimastigotes and metacyclic trypomastigotes was determined by light microscopy and cell counting using a Neubauer chamber. These evolutive forms could be easily differentiated on morphological grounds because epimastigotes are broad and have a rigid body, whereas trypomastigotes are slim and present a wavy movement of the whole body.
Inhibition of epimastigote-to-trypomastigote differentiation with citral -In the first set of experiments, we only added citral to the stress medium, TAU, and tested whether citral would affect the differentiation process of stressed epimastigotes, which occurs in the TAU3AAG medium. We added 50 μg/mL citral to the TAU medium. This concentration was chosen because a previous study showed that the IC 50 /24 h for citral against T. cruzi epimastigotes was about 40 μg/mL (Santoro et al. 2007a ). After incubation for 2 h at 28ºC in this medium, the parasites in the supernatant were observed by light microscopy, collected by centrifugation and transferred to citral-free TAU3AAG medium kept at 28ºC. Culture supernatants were collected after 24, 48 and 72 h of incubation and the number of living epimastigotes and metacyclic trypomastigotes was determined by light microscopy as described above.
In another experiment, epimastigotes were maintained for 2 h at 28ºC in citral-free TAU medium and the stressed parasites were transferred to TAU3AAG medium (kept at 28ºC) containing different citral concentrations (20, 40, 60, 80 or 100 μg/mL). Culture supernatants were collected after 24, 48 and 72 h of incubation and the number of living epimastigotes and metacyclic trypomastigotes was determined by light microscopy as described above.
To examine whether fully differentiated metacyclic trypomastigotes were susceptible to citral, trypomastigotes were obtained after a normal differentiation process in TAU3AAG medium. After 72 h, the resulting trypomastigotes (8 x 10 5 cells/mL) were resuspended in 24-well plates at 4 x 10 5 cells/500 µL TAU3AAG medium per well. Each well contained 0, 20, 40, 60 or 80 μg/mL citral. After a 24 h incubation, the number of living trypomastigotes was assessed by cell counting in a Neubauer chamber to determine the percent of parasite lysis.
To determine whether the effect of citral was reversible, parasites (epimastigotes plus trypomastigotes) were obtained by differentiation in TAU3AAG medium containing 40 μg/mL citral. After 48 h of incubation in this medium, the parasites were resuspended in 24-well plates at 1 x 10 5 cells/mL in citralfree LIT medium (1 mL per well) The number of living epimastigotes in the cultures was assessed daily by cell counting in a Neubauer chamber.
All of these tests were performed in triplicate in three independent experiments.
Electron microscopy -Culture flasks with differentiating epimastigotes in TAU3AAG medium containing 30 μg/mL citral were incubated for 24 h. After incubation, the supernatant was collected and the free-swimming parasites were obtained by centrifugation at 5,500 g for 5 min. To collect the remaining adhered parasites, about 5 mL of TAU3AAG medium was added to the empty flasks, which were vigorously shaken in a vortex for about 2 min. This medium was collected and the procedure was repeated twice. These three aliquots were pooled and centrifuged at 5,500 g for 5 min, which resulted in a pellet of adhered epimastigotes. Free-swimming and adhered parasites were then processed for electron microscopy. Control cultures without citral were also analyzed.
For scanning electron microscopy (SEM), adhered and free-swimming parasites were fixed for 30 min with 2.5% glutaraldehyde in 0.1 M phosphate buffer and then adhered for 10 min to glass coverslips coated with 0.1% poly-L-lysine. The samples were washed in buffer and post-fixed for 15 min with 1% osmium tetroxide in 0.1 M cacodylate buffer (pH 7.2). Thereafter, the samples were dehydrated in graded acetone, critical-point dried and mounted on SEM stubs. The samples were coated with a 20-nm thick gold layer and examined in a Jeol JSM-6360LV scanning electron microscope.
For transmission electron microscopy, adhered and free-swimming parasites were washed in 0.1 M phosphate buffer (pH 7.2) and fixed for 30 min with 2.5% glutaraldehyde in 0.1 M phosphate buffer. The cells were then washed once with 0.1 M phosphate buffer, once with 0.1 M cacodylate buffer and post-fixed for 15 min with 1% osmium tetroxide, 0.8% potassium ferricyanide and 5 mM CaCl 2 in 0.1 M cacodylate buffer (pH 7.2). Cells were rinsed in buffer, dehydrated in graded acetone, infiltrated overnight in a 100% acetone/PolyBed 812 mixture (1:1) and embedded for 72 h at 60ºC in PolyBed 812 (PolySciences, Warrington, PA, USA) resin. Ultrathin sections were stained with 5% uranyl acetate and lead citrate and observed in a Jeol 1200EXII transmission electron microscope.
RESULTS
Citral added to TAU medium does not influence metacyclogenesis -First, we analyzed whether 50 μg/ mL citral added to epimastigotes maintained in the stress medium, TAU, would influence the metacyclogenesis process. The results showed that this concentration of citral did not have an effect on the differentiation rate. Indeed, about 80% of the cells were in the trypomastigote form 48-72 h after being transferred to citral-free TAU3AAG (differentiation) medium. This differentiation rate was similar to the rate in the controls. Light microscopy showed that most cells from control and citral-treated culture supernatants appeared as long epimastigotes, which confirmed that citral treatment for 2 h in TAU medium had no effect on parasite morphology and differentiation potential.
Citral added to TAU3AAG medium inhibits metacyclogenesis in a concentration-dependent manner -A different result was obtained when citral was added only to the differentiation medium, TAU3AAG. Although no effect was observed at 20 μg/mL, metacyclogenesis was almost totally abolished at 40 μg/mL after 24, 48 or 72 h of incubation. Higher concentrations (60, 80 or 100 μg/mL) induced 100% cell lysis. We determined that the IC 50 /24 h of citral was 30.8 μg/mL ( Fig. 2A ). An additional experiment, which was performed with 30 μg/mL citral added to the TAU3AAG medium, confirmed the estimated calculation. Indeed, metacyclogenesis was inhibited by about 54% and 45% after 24 h and 48 h, respectively. Fig. 2A : estimative of the IC 50 /24 h (concentration that inhibited metacyclogenesis in 50% after incubation for 24 h) of citral in triatomine artificial urine (TAU)3AAG medium. The value obtained was about 30.8 μg/ mL. Each point represents the mean and standard deviation (SD) values; B: estimative of IC 50 /24 h for metacyclic trypomastigotes incubated for 24 h in TAU3AAG medium containing different citral concentrations. The IC 50 /24 h was estimated as about 24.5 µg/mL; C: reversibility assay. Parasites were pre-treated for 48 h with 40 µg/mL citral in TAU3AAG medium and then transferred to citral-free liver infusion tryptose medium. Epimastigote growth in the cultures was then estimated by daily cell counting in Neubauer chamber. Each point represents the mean and SD values. □: control; ▲: parasites from cultures containing 40 µg/mL citral.
Treatment with citral blocks cell differentiation but
does not affect epimastigote adhesion -We used light microscopy to examine living, free-swimming parasites from cultures maintained for 24 h in TAU3AAG medium with 40 µg/mL citral. Although most cells in the supernatant of the control medium displayed the characteristic morphology of metacyclic trypomastigotes, most cells in the supernatant of cultures treated with 40 µg/mL citral kept the epimastigote form. The adhesion process, however, was not affected and similar numbers of adhered parasites were observed in treated and untreated culture flasks (data not shown). Nevertheless, parasites from treated cultures presented morphological alterations and showed rounded bodies or signs of cell extraction when compared with the controls. Although citral treatment did not block adhesion, these results indicate that citral treatment affected factors that trigger the T. cruzi differentiation process.
Metacyclic trypomastigotes are more susceptible to citral than epimastigotes -To determine whether metacyclic trypomastigotes were more susceptible to citral than epimastigotes, trypomastigotes were obtained after a normal differentiation process for 72 h in TAU3AAG medium and incubated for 24 h in TAU3AAG medium containing 0, 20, 40, 60 or 80 μg/mL citral. There was a concentration-dependent effect and 60 μg/mL citral killed almost all of the parasites. The IC 50 /24 h was estimated to be 24.5 μg/mL (Fig. 2B) .
Effect of citral on epimastigotes is reversible -Although citral effectively inhibited the epimastigote to trypomastigote differentiation, its effect on epimastigote growth was reversible. Epimastigote growth resumed when parasites treated with 40 μg/mL citral in TAU3AAG medium were washed in LIT medium and incubated in citral-free LIT medium (Fig. 2C) .
Citral induces morphological alterations during T. cruzi differentiation -SEM of differentiating parasites treated with 30 μg/mL citral (corresponding to the IC 50 /24 h value) confirmed the results obtained by light microscopy. Most treated epimastigotes, whether they were in the supernatant (Fig. 3B, C) or adhered to the walls of the flasks (Fig. 3E, F) , presented a rounded body, whereas the control cells had an elongated body (Fig. 3A, D) . Transmission electron microscopy ( Fig. 4A-D) showed that incubation for 24 h in medium containing 30 µg/mL citral caused the parasites in the supernatant to have a rounded form with swelling of the mitochondrion and a loose arrangement of the kDNA network (Fig. 4C) . Adhered parasites that retained the epimastigote form showed few morphological alterations, except for the presence of a higher number of cytoplasmic vacuoles (Fig. 4D) .
DISCUSSION
C. citratus, popularly known as citronella grass or lemongrass, is a perennial grass that is widespread throughout the world. The anti-microbial and anti-fungal activities of lemongrass essential oil, which are primarily due to its main constituent citral (Onawunmi et al. 1984) , have been known for a long time (Kurita et al. 1981 , Mishra & Dubey 1994 ). The present study was the first to show the inhibitory effects of citral on the differentiation process (metacyclogenesis) of T. cruzi in vitro. Our data demonstrated that incubation with citral decreased epimastigote differentiation efficiency in vitro, which resulted in cultures with low numbers of trypomastigotes. Furthermore, epimastigote adhesion was not blocked with the citral treatment, which suggested that citral affects factors that trigger the T. cruzi differentiation process. Therefore, citral may be useful in experiments analyzing the molecules involved in T. cruzi differentiation. During in vivo metacyclogenesis, adhesion of epimastigotes to a substrate was thought to be a prerequisite for differentiation into metacyclic trypomastigotes . The role of adhesion in stimulating differentiation remains unknown, but both adhesion and cell differentiation have been shown to be initiated by a nutritional stress stimulus (Figueiredo et al. 2000) .
Addition of 50 μg/mL citral to TAU stress medium containing epimastigotes did not influence the metacyclogenesis process when the treated parasites were transferred to citral-free TAU3AAG medium. Because the TAU medium with epimastigotes/citral was diluted at 1:100 in TAU3AAG, there was a final concentration of 0.5 μg/mL citral in TAU3AAG, which apparently had no influence on the differentiation process. Our morphological data showed that incubation for 2 h in citral-TAU medium did not result in any morphological alteration of the parasites. The incubation time, however, may not have been long enough to cause any metabolic disturbance in the cells. When citral (20-100 µg/mL) was added directly to the TAU3AAG medium, we observed a strong concentration-dependent influence on the parasites.
Interestingly, a previous study on the incubation of T. cruzi epimastigotes and bloodstream trypomastigotes with lemongrass essential oil and citral also showed a concentration-dependent effect (Santoro et al. 2007a) . For epimastigotes, the IC 50 /24 h value was 126.5 µg/mL for the oil and 42 µg/mL for citral (Santoro et al. 2007a) . For bloodstream trypomastigotes, IC 50 /24 h values were 15.5 µg/mL for the oil and 14.2 µg/mL for citral. Almost 100% trypomastigote lysis was obtained with 50 µg/mL citral (Santoro et al. 2007a ). The present study observed about 90% cell lysis for metacyclic trypomastigotes after treatment with 60 µg/mL citral and the IC 50 /24 h was estimated to be 24.5 μg/mL, which confirmed the results of the Santoro et al. (2007a) . Trypomastigotes were more susceptible to citral than epimastigotes and bloodstream trypomastigotes were more susceptible to citral than in vitro-derived metacyclic trypomastigotes. Because epimastigotes, bloodstream trypomastigotes and metacyclic trypomastigotes have different metabolisms and different glycoconjugate compositions at the cell membrane (de Andrade et al. 1991 , de Souza 2008 , these different susceptibilities could be due to different cell permeability rates for citral or different cellular targets.
Our data showed that treatment with citral induced ultrastructural alterations in the parasites, such as rounding of the body and cell vacuolization. An important characteristic of essential oils and their components is their hydrophobicity (Burt 2004) . Indeed, hydrophobicity allows the essential oils to permeate the cell membrane and kill T. cruzi parasites by affecting cytoplasmic metabolic pathways or organelles (Santoro et al. 2007a) . Essential oils permeate the cell membranes and disrupt the structure of the different layers of membrane polysaccharides, fatty acids and phospholipids, which permeabilizes the membranes (Bakkali et al. 2008) . Essential oil cytotoxicity appears to include membrane damage, which leads to the leakage of macromolecules and lysis (Juven et al. 1994 , Gustafson et al. 1998 , Cox et al. 2000 , Lambert et al. 2001 , Oussalah et al. 2006 ). Because our microscopy findings indicated that citral treatment resulted in rounding of the parasite body with cell vacuolization, the T. cruzi cell membranes may have been permeabilized by citral, which would lead to organelle toxicities, cytoplasmic leakage and cell lysis.
In eukaryotic cells, studies have shown that essential oils can provoke depolarization of the mitochondrial membranes and permeabilization of the outer and inner mitochondrial membranes, which leads to cell death by apoptosis and necrosis (Yoon et al. 2000 , Armstrong 2006 ). The damaged mitochondria result in changes in electron flow through the electron transport chain, which can produce free radicals that oxidise and damage lipids, proteins and DNA (Bakkali et al. 2008 ). Because we observed mitochondrial swelling in citral-treated T. cruzi parasites, it is possible that such events may be occurring in this parasite.
Similar growth inhibition results have been described with C. citratus essential oil assays of other trypanosomatids. Indeed, studies have demonstrated the in vitro activity of this essential oil against C. deanei, with mean IC 50 values for symbiont-bearing and symbiont-free strains of 120 and 60 μg/mL, respectively (Pedroso et al. 2006) . Interestingly, L. amazonensis promastigotes were more sensitive to the essential oil and citral, with IC 50 of about 1.7 and 8.0 μg/mL, respectively, after 72 h of incubation (Santin et al. 2009 ). One study showed that 3.1 µM concentrations of neral or geranial (isomers of citral) were effective against epimastigotes of T. cruzi (Saeidnia et al. 2004) . Another study showed that citral presented high activity against T. cruzi bloodstream trypomastigotes (Santoro et al. 2007a ). In addition, recent data demonstrated a concentration-dependent anti-proliferative activity of citral-rich essential oil from C. citratus on promastigotes, axenic amastigotes and intracellular amastigotes of L. amazonensis (Santin et al. 2009 ).
Studies of T. cruzi in mouse peritoneal macrophages demonstrated that the use of C. citratus essential oil resulted in a selectivity index (the ratio of the IC 50 value in the host cell divided by the IC 50 value of the parasite) close to two (Santoro et al. 2007a ). The expected value for a good drug candidate, however, is greater than 50 (Romanha et al. 2010) . Despite the toxicity to mouse macrophages, the testing of citral derivatives appears to be an alternative in the search for new chemotherapeutic drugs.
Data from the literature have shown that the metacyclogenesis process of T. cruzi could be inhibited by the topoisomerase II inhibitor ofloxacin (Gonzales-Perdomo et al. 1990 ), the antitubulin drug trifluralin (Bogitsh et al. 1999) , the proteasome inhibitor lactacystin (Cardoso et al. 2008 ), metallo and cysteine-protease inhibitors (Bonaldo et al. 1991) or mannose (Barbieri et al. 1992) . The data from the present paper showed that citral effectively blocked the metacyclogenesis of T. cruzi in vitro. In addition, citral killed the resulting metacyclic trypomastigote form, which may have occurred through alterations of membrane permeability. Therefore, citral appears to be a good inhibitory drug candidate for studies on the T. cruzi metacyclogenesis process.
